Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer

NCT00707304

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Desert Oasis Cancer Center Casa Grande, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Pasco Pinellas Cancer Center New Port Richey, Florida, United States
View all 189 locations
View Trial Details
Completed

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00005093

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 16 locations
View Trial Details
Completed

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

NCT00085839

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • California Cancer Care, Inc. Greenbrae, California, United States
  • Sharp Clinical Oncology Research San Diego, California, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • University of Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

NCT00294762

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Central Hematology Oncology Medical Group Inc. Alhambra, California, United States
  • Comprehensive Blood and Cancer Center(Part of TORI network) Bakersfield, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • Virginia K. Crosson Cancer Center Fullerton, California, United States
View all 43 locations
View Trial Details
Completed

A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

NCT00680940

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Gujarat Cancer & Research Institute, New Civil Hospital Campus Asarwa, Ahmedabad, India
  • Regional Cancer Center, Indira Gandhi Medical College Shimla, Himachal Pradesh, India
  • MNJ Institute of Oncology, Regional Cancer Centre Red Hills, Hyderabad, India
  • Malabar Institute of Medical Science (MIMS) Calicut, Kerala, India
View all 14 locations
View Trial Details
Completed

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

NCT00370383

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Kenmar Research Institute Los Angeles, California, United States
  • Memorial Cancer Institute Hollywood, Florida, United States
View all 16 locations
View Trial Details

Related conditions